CONDUIT PHARMACEUTICALS INC
For the period ended Dec 31, 2023. Filed Apr 16, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 16, 2024
CDT$1.31+54.8%Stored close · as of Nov 6, 2026
Opening this filing…